| Application no. and date | 17179369.8 (espacenet) (Federated) (European Patent Register), 20091130 | | Patent/reg. no. and date | DK/EP 3279195, 20200701 | | Publication date | 20180207 | | Priority no. and date | US 118796 P, 20081201 | | EP pub. no. and date |
EP 3279195 20180207 | | Effective date | | | Applicant/owner | Oyster Point Pharma, Inc., 202 Carnegie Center, Suite 109
Princeton, New Jersey 08540, US | | Applicant ref. no. | COOQ/P48866EPdiv1 | | Inventor | MILLER, Craig, Harrison, 1564 Sharon Road
Winston-Salem, NC 27103, US,
Munoz, Julio A., 214 Lakeside Drive
Walnut Cove, NC 27052, US,
CUTHBERTSON, Timothy J., 2661 Belwick Village
Winston-Salem, NC 27106, US,
DULL, Gary Maurice, 6025 Shallowford Road
Lewisville, NC 27023, US,
Akireddy, Srinivisa Rao, 5829 Fox Point Circle
Winston-Salem, NC 27104, US,
Otten, Pieter Albert, 1065 Homestead Place Drive
King, NC 27021, US,
Bhatti, Balwinder Singh, 2536 Polo Road
Winston-Salem, NC 27106, US,
Mitchener, JR., Joseph Pike, 3609 Wickersham Lane
Winston-Salem, NC 27106, US | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 4. tv., 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 25/00 (2006.01) , C07D 403/06 (2006.01) | | Title | Synthesis and novel salt forms of (R)-5-((E)-2-(pyrrolidin-3-ylvinyl)pyrimidine | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
